The era of base editing!

Finally, in vivo mRNA-based genome editing therapy has been successful in treating rare genetic diseases in children. More specifically, this is the result of a highly safe base editing technology that does not involve genome cutting. This is a technological breakthrough that expands the possibilities of N of 1.
https://miyata-bio.net/column/0000468/